Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

NCT07716189 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Interventions

DRUG: Auricular point stimulation plus dexamethasone
DRUG: Standard pharmacologic antiemetic regimen

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine